Phylogica Limited

ASX:PYC ISIN:AU000000PYC7

Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.  
 
        

Lihat di Bahasa Lain

Berita

Laporan Pasar Australia 20 Desember 2010: IMX Resources (ASX:IXR) Meluncurkan Pengapalan Pertama Biji Tembaga Besinya ke Cina

🕔12/20/2010 1:30:00 PM 12715

Laporan Pasar Australia 20 Desember 2010 memuat: IMX Resources Limited (ASX:IXR) telah meluncurkan pengapalan pertamanya untuk biji tembaga besi ke Cina; Phylogica Limited (ASX:PYC) menanda tangani perjanjian kolaborasi danlisensi dengan Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) menerima hasil yang kuat untuk tembaga, perak, kobalt di Walford Creek, Queensland Baratlaut; Produksi biji besi South American Ferro Metals Limited (ASX:SFZ) di Brazil melampaui 400.000 ton.

Baca Full Story▸
###

80,732 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 14) (30 Hari Terakhir: 97) (Sejak Ditampilkan: 8432) 

Data Perusahaan

    Fax
  • 08 9423 8899 
    • Sektor Utama
  • Kesehatan & Pharm 
    • Industri Utama
  • Biotechnology 
    • Homepage
  • www.phylogica.com/

Lebih banyak Berita lagi

  • 2024/05/09: Q2 2024 Investor Webinar Presentation*
  • 2024/05/06: Presentation of RP11 Clinical Trial Data at ARVO Conference*
  • 2024/05/01: Ceasing to be a substantial holder*
  • 2024/05/01: Q2 Investor Webinar 9 May 2024*
  • 2024/04/30: Application for quotation of securities - PYC*
  • 2024/04/29: RP11 Drug Candidate Progressing to Mid-Stage Human Trials*
  • 2024/04/26: Quarterly Activities/Appendix 4C Cash Flow Report*
  • 2024/04/22: Kidney Disease Drug Candidate Progressing to Human Trials*
  • 2024/04/17: Change in substantial holding*
  • 2024/04/15: Update - Application for quotation of securities - PYC*
*refer to company website